| Literature DB >> 32898141 |
Hayley Alderson1, Eileen Kaner1, Elaine McColl1, Denise Howel1, Tony Fouweather1, Ruth McGovern1, Alex Copello2, Heather Brown1, Paul McArdle3, Deborah Smart1, Rebecca Brown1, Raghu Lingam4.
Abstract
BACKGROUND: Young people in state care, often due to abuse or neglect, have a four-fold increased risk of drug and alcohol use compared to their peers. AIM: The SOLID study aimed to investigate the feasibility of a definitive randomised controlled trial, comparing two behaviour change interventions to reduce risky substance use (illicit drugs and alcohol), and improve mental health, in young people in care.Entities:
Mesh:
Year: 2020 PMID: 32898141 PMCID: PMC7478815 DOI: 10.1371/journal.pone.0238286
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Study procedures.
| Randomisation Unit | Individual |
|---|---|
| Minimum of 35 young people in care per arm (3 arm trial) | |
| active intervention arms: | |
| • 6 sessions of MET or | |
| • 6 sessions of SBNT | |
| Usual social worker delivered care with additional signposting to local drug and alcohol third sector services. | |
| • Young people in care aged ≥12 and ≤20 years. | |
| • Screened positive for being at risk of substance misuse i.e. score ≥1 on CRAFFT. | |
| • Provided informed consent to take part in the study: for young people under 16 years consent from foster parent/guardian (local authority) and assent from young person was required; for young people 16 years and over, consent was taken directly from young person. | |
| • Already in active treatment with drug and alcohol services. | |
| • Unable to access drug and alcohol services e.g. due to currently residing out of the study area, an imminent move out of area or being in young offender’s institution/prison/a secure unit. | |
| • Unable to give informed consent (due to acute or severe mental health difficulties, mental capacity or language barriers- this was assessed by the individual with parental responsibility). | |
| Stop Go criteria: | |
| Definite Go (‘green light’) defined as: | |
| • ≥60% of eligible participants consenting to pilot trial | |
| • ≥80% of those in the intervention arms receiving intervention as planned | |
| • ≥ 70% retention of consented participants to 12 months follow up assessment | |
| Definite Stop (‘red light’) defined as: | |
| • <40% of eligible participants consenting to pilot trial | |
| • <20% of those in the intervention arms receiving intervention as planned | |
| • <50% retention of consented participants to 12 months follow up assessment. | |
| • Episodes of heavy episodic drinking (≥5 units in 1 day) in the preceeding 30 day period | |
| • Frequency of use of the most problematic classified substance in preceeding 30 days (data from TLFB-30) | |
| • Mental health and wellbeing: Strength and Difficulties Questionnaire (SDQ) and the Warwick-Edinburgh Mental Well-being scale (WEMWBS). | |
| • Quality of life measured using the EQ-5D-5L. | |
| • Placement stability for the young person | |
| • Sexual behaviour: taken from the computer assisted self-interview (CASI) with questions relating to regret in sexual encounters and unprotected sex used in the ESPAD. | |
| Stratified randomisation based on placement type, local authority site and age band | |
| Blinding of group allocation was not possible for the young people in care participants, or for those delivering the intervention; however, the trial statistician and health economist were blinded to group allocation until the final analysis. |
Baseline and follow- up data collection.
| Screening tool | Purpose | Scoring | Timepoint used |
|---|---|---|---|
| CRAFFT- ( | To reflect participants, own personal perspective of their drug and/or alcohol use and associated risky behaviours. | The screening questionnaire consists of 4 questions in part A and 6 questions in part B. All questions have an option of yes or no. Individuals received a score for each yes response they provided, the higher the score the more substances were being used and the more risky behaviours were taking place. | Screening |
| For SOLID, young people screened positive for being at risk of substance misuse if they scored ≥1 on part A of CRAFFT. | |||
| Alcohol Use Disorder Identification Test (AUDIT) [ | To identify signs of hazardous and harmful drinking and identify mild dependence. | AUDIT is a 10-item scale. Scoring can range from 0–40, a score of 8+ is considered to indicate hazardous or harmful drinking. For the purpose of this study we use adult cut off points as a formal scoring system does not exist for children. | Baseline and Follow up |
| Alcohol, Smoking and Substance Involvement Screening Tool- Youth (ASSIST-Y) [ | To identify moderate and high-risk scores broken down by age and substance. | Questions relate to 9 different substances. | Baseline and follow up |
| For tobacco, alcohol, inhalants–score 2 to 5 moderate risk, score of > 6 high risk. Scores >2 in any other substance indicates high risk | |||
| Any injection of drugs is high risk. | |||
| For tobacco and cannabis—score 2 to 11 moderate risk. For alcohol score 5 to 17 moderate risk. For cocaine, sedatives, opioids, NPS and ‘other’ drugs score 2 to 6 moderate risk. For amphetamines, inhalants and hallucinogens score 2 to 8 moderate risk. | |||
| High risk scores tobacco and cannabis (>12), alcohol (>18), cocaine, sedatives, opioids, NPS and ‘other’ (>7) and amphetamines, inhalants and hallucinogens (> 9). | |||
| Strengths and Difficulties Questionnaire (SDQ) [ | To measure self-reported mental health and wellbeing. | 25 questions to assess four difficulty subscales and measure pro-social behaviour. Total difficulties scores range from 0–40, each one-point increase in this score corresponds with an increased risk of developing mental health disorders; close to average (0–14), slightly raised (15–17), high (18–19), very high (20–40). | Baseline and Follow up |
| Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) [ | To measure subjective well-being and psychological functioning. | 14 item scale with each item scored 1 (none of the time) to 5 (all of the time) on a Likert scale. Total scores range from 0–70, higher scores denote positive mental health; very low score (0–32), below average (32–40), average score (40–59), above average score (59–70). | Baseline and Follow up |
| EQ-5D-5L [ | To assess health-related quality of life- five dimensions of health-related quality of life are assessed (mobility, self-care, usual activities, pain/discomfort and anxiety/depression). | Each dimension has five potential responses ranging from 1 (no problems) to 5 (extreme problems). | Baseline and Follow up |
| The digits for the five dimensions can be combined into a 5-digit number that describes the patient’s health state E.g. 1,1,1,1,1- no problems in any domain or 5,5,5,5,5- extreme problems in all domains. | |||
| Once completed each individual would have a 5-digit code for EQ 5D 5L, such as 41325. | |||
| In addition, a vertical visual analogue scale (VAS) is used for participants to self-rate their health. | |||
| VAS scores range from 0- ‘the worst health you can imagine’ to 100- ‘the best health you can imagine’. | |||
| Time Line Follow Back- 30 (TLFB- 30) [ | The TLFB is a drinking assessment method that obtains estimates of daily drinking (e.g., pattern, variability, and magnitude of drinking). over a 30-day period. | The TLFB in SOLID sought to identify heavy episodic drinking (high intensity ‘binge’ drinking is defined as the 'number of occasions where 5 or more standard drink units are consumed on a single drinking day' as used in the ESPAD survey. [ | Follow up |
* The youth and adult version of the EQ-5D-5L tool can be used for 12–15 year olds and for 16 years plus the adult version is recommended, therefore we used the adult version of the EQ-5D-5L with all participants for consistency across the dataset.
Comparisons between SOLID interventions and usual care.
| SOLID Interventions | Standard Care (2017/2018) |
|---|---|
| • Young people were offered SBNT or MET within 6 weeks of randomisation. | • 97% of young people accessing specialist treatment had to wait 3 weeks or under to start an intervention. |
| • Young people were ineligible if they were already in active treatment | |
| • Interventions not standardised and used several theoretical frameworks | |
| • Interventions would last a maximum of 6 sessions delivered over 12 weeks | |
| • Young people can access 1 or more interventions at the same time | |
| • Average (mean) treatment episode was 4.9 months. |
Assessment of the SOLID stop/go criteria.
| Green criteria | Amber criteria | Red criteria | Outcome | |
|---|---|---|---|---|
| % Eligible young people in care consenting to trial | ≥60% | 40–60% | <40% | |
| % of participants randomised to intervention attending 60% of offered sessions | ≥80% | 20–80% | <20% | |
| % of randomised participants retained to 12 months follow-up | ≥70% | 50–70% | <50% | |
| Intervention delivered with fidelity | Yes (scored 3–4 using PRS | Unclear (scored 1–2 using PRS scale or insufficient data to score) | No (scored 0 using PRS scale) | |
| Intervention perceived acceptable by young people in care and workers. | Yes | Unclear | No | |
| Value of information analysis shows future research is worthwhile | Worthwhile | Unclear | Not worthwhile |
**Process rating Scale- A validated process rating scale which was developed in the UKATT trial [46] was used, the scale covers both MET and SBNT, see S2 File.
Fig 1Consort diagram.
RCT Baseline characteristics.
| MET (n = 38) | SBNT (n = 38) | Usual care (n = 36) | Overall (n = 112) | Screen (n = 860) | |
|---|---|---|---|---|---|
| Male | 17 (45%) | 21 (55%) | 12 (33%) | 50 (45%) | 440 (51%) |
| Female | 21 (55%) | 17 (45%) | 24 (67%) | 62 (55%) | 409 (48%) |
| missing | 11 (1%) | ||||
| n = 858 | |||||
| Median (LQ, UQ) | 18 (16, 19) | 17 (16, 18) | 18 (16, 19) | 17 (16, 19) | 16 (14, 18) |
| Range (min, max) | (13, 21*) | (13, 20) | (13, 20) | (13, 21*) | (12, 20) |
| Mean (SD) | 17.5 (2.1) | 17.0 (1.9) | 17.3 (2.0) | 17.3 (2.0) | 16.1 (2.4) |
| missing | 2 | ||||
| Not available at screening | |||||
| In school | 7 (18%) | 10 (26%) | 7 (19%) | 24 (21%) | |
| Under 16 not in school | 2 (5%) | 1 (3%) | 0 (0%) | 3 (3%) | |
| 6th form/college/ university | 8 (21%) | 12 (32%) | 8 (22%) | 28 (25%) | |
| In training /apprenticeship | 4 (11%) | 4 (11%) | 1 (3%) | 9 (8%) | |
| 16+ not in training, employment or | 15 (39%) | 8 (21%) | 17 (47%) | 40 (36%) | |
| education | 2 (5%) | 3 (8%) | 2 (6%) | 7 (6%) | |
| Over 16 and employed | 0 (0%) | 0 (0%) | 1 (3%) | 1 (<1%) | |
| Foster Care | 9 (24%) | 12 (31%) | 13 (36%) | 34 (30%) | 452 (52%) |
| Residential home | 8 (21%) | 6 (16%) | 6 (17%) | 20 (18%) | 83 (10%) |
| Own accommodation | 21 (55%) | 17 (45%) | 11 (31%) | 49 (44%) | |
| With parents | 0 (0%) | 1 (3%) | 5 (14%) | 6 (5%) | |
| other | 0 (0%) | 2 (5%) | 1 (3%) | 3 (3%) | 249 (29%) |
| missing | 76 (9%) | ||||
| Newcastle | 6 (16%) | 7 (18%) | 7 (19%) | 20 (18%) | 189 (22%) |
| Durham | 12 (32%) | 10 (26%) | 11 (31%) | 33 (29%) | 201 (23%) |
| Gateshead | 4 (11%) | 4 (11%) | 4 (11%) | 12 (11%) | 125 (15%) |
| Middlesbrough | 6 (16%) | 6 (16%) | 5 (14%) | 17 (15%) | 146 (17%) |
| Redcar | 2 (5%) | 3 (8%) | 2 (6%) | 7 (6%) | 95 (11%) |
| Stockton | 8 (21%) | 8 (21%) | 7 (19%) | 23 (21%) | 104 (12%) |
| Not available at screening | |||||
| White British | 38 (100%) | 34 (89%) | 34 (94%) | 106 (95%) | |
| Other ethnicity | 0 (0%) | 4 (11%) | 1 (3%) | 5 (4%) | |
| Missing | 0 (0%) | 0 (0%) | 1 (3%) | 1 (<1%) |
Summary of baseline alcohol and mental health data by trial arm and combined across arms.
| Variable | MET | SBNT | Usual Care | Overall |
|---|---|---|---|---|
| Baseline (n = 38) | Baseline (n = 38) | Baseline (n = 36) | Baseline (n = 111) | |
| Hazardous alcohol | 24 (63%) | 17 (45%) | 20 (57%) | 61 (55%) |
| Alcohol | 37 (97%) | 37 (97%) | 34 (94%) | 108 (97%) |
| Tobacco | 30 (79%) | 30 (79%) | 33 (92%) | 93 (84%) |
| Cannabis | 30 (79%) | 21 (55%) | 30 (83%) | 81 (73%) |
| Cocaine | 14 (37%) | 12 (31.5%) | 14 (39%) | 40 (36%) |
| Amphetamine | 11 (29%) | 11 (29%) | 5 (14%) | 27 (24%) |
| Sedative | 10 (26%) | 7 (18%) | 10 (28%) | 27 (24%) |
| Hallucinogens | 7 (18%) | 6 (16%) | 6 (17%) | 19 (17%) |
| Novel Psychoactive Substance (NPS) | 9 (24%) | 7 (18%) | 3 (8%) | 19 (17%) |
| Opioid | 5 (13%) | 3 (8%) | 3 (8%) | 11 (10%) |
| Inhalants | 2 (5%) | 3 (8%) | 4 (11%) | 9 (8%) |
| Other | 2 (5%) | 0 (0%) | 1 (3%) | 3 (2.7%) |
| Very low score (0–32) | 8 (21%) | 3(8%) | 3 (9%) | 14 (13%) |
| Below average score (32–40) | 9 (24%) | 10 (26%) | 9 (26%) | 28 (25%) |
| Average score (40–59) | 15 (39%) | 20 (53%) | 22 (63%) | 57 (51%) |
| Above average score (59–70) | 6 (16%) | 5 (13%) | 1 (3%) | 12 (11%) |
| Close to average score (0–14) | 15 (39%) | 22 (58%) | 15 (43%) | 52 (47%) |
| Slightly raised score (15–17) | 7 (18%) | 6 (16%) | 3 (9%) | 16 (14%) |
| High score (18–19) | 7 (18%) | 3 (8%) | 4 (11%) | 14 (13%) |
| Very high score (20–40) | 9 (24%) | 7 (18%) | 13 (37%) | 29 (26%) |
| No problems | 15 (39%) | 16 (42%) | 17 (48.5%) | 48 (43.2%) |
| Slight problems | 7 (18%) | 10 (26%) | 10 (28.5%) | 27 (24.3%) |
| Moderate problems | 5 (37%) | 7 (18%) | 5 (14%) | 17 (15.3%) |
| Severe problems | 7 (18%) | 3 (8%) | 2 (6%) | 12 (10.8%) |
| Extreme problems | 4 (29%) | 2 (5%) | 1 (3%) | 7 (6.3%) |
| mean score | 70.44737 | 72.60526 | 71.22857 | 71.43243 |
| Range (min-max) | (5–100) | (10–100) | (20–100) | (5–100) |
** Note that participant 36 (female, 19 years) was randomised but their baseline data did not transfer electronically to the trial database due to a technical fault. This participant’s data could not be included in the baseline analysis, leaving 111 participants providing baseline data.
12-month descriptive data.
| Variable | MET | SBNT | Usual Care | Overall |
|---|---|---|---|---|
| 12 months (n = 17) | 12 months (n = 23) | 12 months (n = 20) | 12 months (n = 60) | |
| Hazardous alcohol | 12 (71%) | 7 (30%) | 10 (50%) | 29 (48%) |
| Alcohol | 17 (100%) | 23 (100%) | 20 (100%) | 60 (100%) |
| Tobacco | 14 (82%) | 18 (78%) | 18 (90%) | 50 (83%) |
| Cannabis | 12 (70.5%) | 14 (61%) | 14 (70%) | 40 (67%) |
| Cocaine | 8 (47%) | 5 (22%) | 7 (35%) | 20 (33%) |
| Amphetamine | 7 (41%) | 7 (30%) | 3 (15%) | 17 (28%) |
| Sedative | 6 (35%) | 4 (17%) | 5 (25%) | 15 (25%) |
| Hallucinogens | 4 (23.5%) | 3 (13%) | 4(20%) | 11 (18%) |
| Novel Psychoactive Substance (NPS) | 3 (18%) | 3 (13%) | 2 (10%) | 8 (13%) |
| Opioid | 2 (12%) | 1 (4%) | 1 (5%) | 4 (7%) |
| Inhalants | 2 (12%) | 1 (4%) | 2 (10%) | 5 (8%) |
| Other | 0 (0%) | 0(0%) | 0 (0%) | 0 (0%) |
| Very low score (0–32) | 5 (29%) | 4 (17%) | 3 (15%) | 12 (20%) |
| Below average score (32–40) | 2 (12%) | 2 (9%) | 2 (10%) | 6 (10%) |
| Average score (40–59) | 9 (53%) | 15 (65%) | 14 (70%) | 38 (63%) |
| Above average score (59–70) | 1 (6%) | 2 (9%) | 1 (5%) | 4 (7%) |
| Close to average score (0–14) | 5 (29%) | 13 (57%) | 12 (60%) | 30 (50%) |
| Slightly raised score (15–17) | 1 (6%) | 4 (17%) | 2 (10%) | 7 (12%) |
| High score (18–19) | 3 (18%) | 2 (9%) | 2 (10%) | 7 (12%) |
| Very high score (20–40) | 8 (47%) | 4 (18%) | 4 (20%) | 16 (27%) |
| No problems | 2 (12%) | 10 (43%) | 8 (40%) | 20 (33%) |
| Slight problems | 5 (29%) | 6 (26%) | 5 (25%) | 16 (27%) |
| Moderate problems | 6 (35%) | 4 (17%) | 5 (25%) | 15 (25%) |
| Severe problems | 3 (18%) | 2 (7%) | 1 (5%) | 6 (10%) |
| Extreme problems | 1 (6%) | 1 (4%) | 1 (5%) | 3 (5%) |
| mean score | 65.47059 | 80.47826 | 69.5 | 72.56667 |
| Range (min-max) | (40–100) | (35–100) | (10–100) | (10–100) |
| Number at follow up (% of randomised) | 17 (45%) | 22 | 20 (56%) | 59 (53%) |
| Median (LQ, UQ) | 1 (0, 4) | 0 (0, 2) | 1.5 (0, 5.5) | 1 (0, 4) |
| Range (min, max) | (0, 10) | (0, 7) | (0, 9) | (0, 10) |
*Note that one participant did not complete the TLFB at follow up. They did however complete all other questionnaires at that time